Seagen upgraded to buy from neutral at BofA Securities

1 BUSINESS

Business News - Opportunities - Reviews

 

 

Seagen Inc.

Seagen Inc. is a biotechnology company, which engages in the development and commercialization of antibody-based therapies for the treatment of cancer. Its products include Adcetris and Padcev. The firm is also advancing a pipeline of novel therapies for solid tumors and blood-related cancers. The company was founded by Clay B. Siegall and H. Perry Fell on July 15, 1997 and is headquartered in Bothell, WA.

1 BUSINESS

Business News - Opportunities - Reviews

 

 

Leave a Reply